Measles vaccine

Measles Vaccine

A vial of the measles vaccine.

Overview

The measles vaccine is a highly effective immunization tool against measles, a highly contagious viral disease. It is a cornerstone in public health initiatives worldwide due to its efficacy and role in measles eradication efforts.

Development and Types

The measles vaccine was developed in the 1960s and has undergone several advancements since. There are different types of measles vaccines, including monovalent (measles only) and combination vaccines like MMR (measles, mumps, and rubella).

Efficacy and Immunity

• Initial Dose: A single dose of the measles vaccine is highly effective in developing immunity in most individuals.
• Second Dose: For those who do not develop immunity from the first dose, a second dose almost always ensures immunity.
• Longevity of Immunity: The vaccine's effectiveness is known to last for many years, although the exact duration of immunity is still under study.

Herd Immunity and Outbreak Prevention

• Herd Immunity Threshold: When vaccination rates in a population exceed 92%, herd immunity is achieved, significantly reducing the likelihood of measles outbreaks.
• Importance of Vaccination Rates: Maintaining high vaccination rates is crucial to prevent the resurgence of measles outbreaks.

Vaccine Administration

The measles vaccine is typically administered in childhood as part of routine immunization schedules. It is often combined with mumps and rubella vaccines (MMR) for broader protection.

Post-Exposure Efficacy

In some cases, administering the measles vaccine within a couple of days after exposure to the measles virus can provide protection against the disease.

Safety and Side Effects

The measles vaccine is generally safe, with side effects being rare and usually mild, such as fever or mild rash. Severe side effects are extremely rare.

Global Impact

The widespread use of the measles vaccine has led to a significant decline in measles cases and fatalities globally, playing a pivotal role in public health.

Challenges and Future Directions

Despite its success, challenges such as vaccine hesitancy and access in remote areas persist. Continuous efforts are needed to maintain high vaccination coverage and move towards global eradication of measles.

See Also

• Vaccination
• Herd Immunity
• Infectious Diseases

References

• World Health Organization - Measles
• CDC - Measles Vaccination
• National Center for Biotechnology Information - Measles Vaccine Research

Measles vaccine Resources
Latest articles Most recent articles Ongoing trials	Wikipedia